Parkinson Disease (diet therapy) < Parkinson Disease (drug therapy) < Parkinson Disease (economics)

Facettes :

List of bibliographic references

Number of relevant bibliographic references: 472.
[20-40] [0 - 20][0 - 50][40-60]

Ident.	Authors (with country if any)	Title
000080 (1999)	Yves Agid [France] ; E. Ahlskog ; A. Albanese ; D. Calne ; T. Chase ; J. De Yebenes ; S. Factor ; S. Fahn ; O. Gershanik ; C. Goetz ; W. Koller ; M. Kurth ; A. Lang ; A. Lees ; P. Lewitt ; D. Marsden ; E. Melamed ; P P Michel ; Y. Mizuno ; J. Obeso ; W. Oertel ; W. Olanow ; Werner Poewe [Autriche] ; P. Pollak ; E. Tolosa	Levodopa in the treatment of Parkinson's disease: a consensus meeting.
000081 (1999)	C. Dentresangle [France] ; L. Veyre ; D. Le Bars ; C. Pierre ; F. Lavenne ; P. Pollak ; J. Guerin ; J C Froment ; E. Brousolle	Striatal D2 dopamine receptor status in Parkinson's disease: an [18F]dopa and [11C]raclopride PET study.
000083 (1999)	S. Mesure [France] ; J P Azulay ; J. Pouget ; B. Amblard	Strategies of segmental stabilization during gait in Parkinson's disease.
000085 (1999)	L. Vercueil [France] ; J P Linard ; B. Wuyam ; P. Pollak ; G. Benchetrit	Breathing pattern in patients with Parkinson's disease.
000098 (2000)	P. Damier [France] ; L. Tremblay ; J. Féger ; E C Hirsch	[Development of dyskinesias induced by treatment for Parkinson's disease: potential role of first exposure to L-DOPA (or phenomenon of priming)].
000099 (????)		[Parkinson disease].
000102 (2000)	B P Bejjani [France] ; D. Dormont ; B. Pidoux ; J. Yelnik ; P. Damier ; I. Arnulf ; A M Bonnet ; C. Marsault ; Yves Agid [France] ; J. Philippon ; P. Cornu	Bilateral subthalamic stimulation for Parkinson's disease by using three-dimensional stereotactic magnetic resonance imaging and electrophysiological guidance.
000103 (2000)	E C Hirsch [France]	Nigrostriatal system plasticity in Parkinson's disease: effect of dopaminergic denervation and treatment.
000104 (2000)	A L Benabid [France] ; A. Benazzouz ; P. Limousin ; A. Koudsie ; P. Krack ; B. Piallat ; P. Pollak	Dyskinesias and the subthalamic nucleus.
000105 (2000)	B. Bejjani ; D. Gervais ; I. Arnulf ; S. Papadopoulos ; S. Demeret ; A. Bonnet ; P. Cornu ; P. Damier ; Yves Agid [France]	Axial parkinsonian symptoms can be improved: the role of levodopa and bilateral subthalamic stimulation
000108 (2000)	S. Meunier [France] ; S. Pol ; J L Houeto ; M. Vidailhet	Abnormal reciprocal inhibition between antagonist muscles in Parkinson's disease.
000110 (2000)	N. Fournet [France] ; O. Moreaud ; J L Roulin ; B. Naegele ; J. Pellat	Working memory functioning in medicated Parkinson's disease patients and the effect of withdrawal of dopaminergic medication.
000112 (2000)	B P Bejjani [France] ; I. Arnulf ; S. Demeret ; P. Damier ; A M Bonnet ; J L Houeto ; Yves Agid [France]	Levodopa-induced dyskinesias in Parkinson's disease: is sensitization reversible?
000116 (2000)	O. Rascol [France] ; D J Brooks ; A D Korczyn ; P P De Deyn ; C E Clarke ; A E Lang	A five-year study of the incidence of dyskinesia in patients with early Parkinson's disease who were treated with ropinirole or levodopa.
000127 (2000)	O. Rascol [France] ; J L Montastruc	[Role of dopaminergic agonists].
000129 (2000)	B. Pillon [France] ; C. Ardouin ; P. Damier ; P. Krack ; J L Houeto ; H. Klinger ; A M Bonnet ; P. Pollak ; A L Benabid ; Yves Agid [France]	Neuropsychological changes between "off" and "on" STN or GPi stimulation in Parkinson's disease.
000132 (2000)	J J Ferreira [France] ; O. Rascol	Prevention and therapeutic strategies for levodopa-induced dyskinesias in Parkinson's disease.
000137 (2000)	O. Rascol [France]	The pharmacological therapeutic management of levodopa-induced dyskinesias in patients with Parkinson's disease.
000160 (2001)	L. Pezard [France] ; R. Jech ; E. Růzicka	Investigation of non-linear properties of multichannel EEG in the early stages of Parkinson's disease.
000163 (2001)	O. Rascol [France] ; J G Nutt ; O. Blin ; C G Goetz ; J M Trugman ; C. Soubrouillard ; J H Carter ; L J Currie ; N. Fabre ; C. Thalamas ; W W Giardina ; S. Wright	Induction by dopamine D1 receptor agonist ABT-431 of dyskinesia similar to levodopa in patients with Parkinson disease.
000174 (2001)	F. Durif [France] ; I. Devaux ; J J Pere ; J C Delumeau ; I. Bourdeix	Efficacy and tolerability of entacapone as adjunctive therapy to levodopa in patients with Parkinson's disease and end-of-dose deterioration in daily medical practice: an open, multicenter study.

---

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Wicri/Sante/explor/ParkinsonFranceV1/Data/Ncbi/Curation

HfdIndexSelect -h $EXPLOR_AREA/Data/Ncbi/Curation/KwdEn.i -k "Parkinson Disease (drug therapy)" 

HfdIndexSelect -h $EXPLOR_AREA/Data/Ncbi/Curation/KwdEn.i  \
                -Sk "Parkinson Disease (drug therapy)" \
         | HfdSelect -Kh $EXPLOR_AREA/Data/Ncbi/Curation/biblio.hfd 

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Wicri/Sante
   |area=    ParkinsonFranceV1
   |flux=    Ncbi
   |étape=   Curation
   |type=    indexItem
   |index=    KwdEn.i
   |clé=    Parkinson Disease (drug therapy)
}}

---

This area was generated with Dilib version V0.6.29. Data generation: Wed May 17 19:46:39 2017. Site generation: Mon Mar 4 15:48:15 2024